Phase Ib multiple-dose trial of brilacidin [PMX 30063] in volunteers.
Phase of Trial: Phase I
Latest Information Update: 05 Jun 2017
At a glance
- Drugs Brilacidin (Primary)
- Indications Staphylococcal infections
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 05 Jun 2017 Results presented at the ASM Microbe 2017
- 10 May 2011 Results presented at the 21st European Congress of Clinical Microbiology and Infectious Diseases and the 27th International Congress of Chemotherapy.
- 31 Mar 2010 Status changed from recruiting to completed.